Silvant Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-28,009
Closed -$1.79M 318
2025
Q1
$1.79M Hold
28,009
0.08% 129
2024
Q4
$3.41M Hold
28,009
0.14% 92
2024
Q3
$3.5M Buy
28,009
+2,950
+12% +$368K 0.15% 90
2024
Q2
$3.96M Buy
25,059
+9,221
+58% +$1.46M 0.18% 77
2024
Q1
$2.05M Hold
15,838
0.1% 118
2023
Q4
$1.53M Hold
15,838
0.08% 125
2023
Q3
$1.92M Hold
15,838
0.12% 111
2023
Q2
$1.81M Sell
15,838
-8,096
-34% -$927K 0.1% 115
2023
Q1
$3.3M Buy
23,934
+5,616
+31% +$774K 0.21% 85
2022
Q4
$2.37M Buy
18,318
+14,290
+355% +$1.85M 0.17% 100
2022
Q3
$445K Hold
4,028
0.03% 151
2022
Q2
$302K Hold
4,028
0.07% 125
2022
Q1
$315K Hold
4,028
0.06% 140
2021
Q4
$363K Sell
4,028
-259
-6% -$23.3K 0.06% 134
2021
Q3
$396K Hold
4,287
0.07% 133
2021
Q2
$333K Hold
4,287
0.05% 151
2021
Q1
$320K Sell
4,287
-106
-2% -$7.91K 0.05% 153
2020
Q4
$749K Hold
4,393
0.13% 106
2020
Q3
$617K Hold
4,393
0.12% 105
2020
Q2
$704K Hold
4,393
0.13% 101
2020
Q1
$430K Hold
4,393
0.09% 111
2019
Q4
$567K Hold
4,393
0.1% 105
2019
Q3
$331K Hold
4,393
0.07% 135
2019
Q2
$668K Hold
4,393
0.12% 104
2019
Q1
$524K Hold
4,393
0.09% 110
2018
Q4
$479K Hold
4,393
0.1% 112
2018
Q3
$710K Hold
4,393
0.09% 107
2018
Q2
$581K Sell
4,393
-807
-16% -$107K 0.07% 109
2018
Q1
$385K Buy
+5,200
New +$385K 0.05% 138